2025-10-19 - Analysis Report
Okay, here's an analysis of Albemarle Corp (ALB) based on the provided data, formatted as requested.

## Albemarle Corp (ALB) Analysis

**Company Overview:** Albemarle Corp is a specialty chemicals company with leading positions in lithium, bromine, and catalysts.

**1. Performance vs. S&P 500 (VOO)**

*   **Cumulative Return Difference:** ALB -10.47% vs. VOO 97.05% (Difference: -107.52%)
*   **Relative Deviation:** Current: -103.5, Relative: 5.5
*   **Analysis:** ALB has significantly underperformed the S&P 500. The relative deviation suggests that ALB is currently near the lower end of its historical performance range relative to the S&P 500.

**Alpha, Beta Analysis Table:**

| Year       | CAGR     | MDD    | Alpha   | Beta   | Cap(B) |
|------------|----------|--------|---------|--------|--------|
| 2015-2017  | 85.0%    | 68.0%  | 56.0%   | 0.1    | 15.1   |
| 2016-2018  | 9.0%     | 68.0%  | -6.0%   | 0.0    | 9.1    |
| 2017-2019  | -44.0%   | 73.9%  | -66.0%  | 0.1    | 8.6    |
| 2018-2020  | 44.0%    | 79.4%  | 20.0%   | 0.2    | 17.4   |
| 2019-2021  | 149.0%   | 79.4%  | 103.0%  | -0.1   | 27.5   |
| 2020-2022  | 148.0%   | 79.9%  | 149.0%  | 0.5    | 25.5   |
| 2021-2023  | -26.0%   | 81.9%  | -27.0%  | 0.5    | 17.0   |
| 2022-2024  | -152.0%  | 81.9%  | -172.0% | 0.3    | 10.1   |
| 2023-2025  | -232.0%  | 81.9%  | -293.0% | -0.5   | 10.9   |

*   **CAGR Trend:**  Volatile. High growth in some periods, significant declines in others.  Recent years (2022-2025) show sharp negative CAGR.
*   **MDD:** High Maximum Drawdown (MDD) consistently above 68%, indicating significant price volatility and risk.
*   **Alpha:** Alpha fluctuates significantly, with recent periods showing large negative values, indicating considerable underperformance relative to the benchmark.
*   **Beta:**  Beta values are generally low, suggesting ALB has not been highly correlated with the market, though there are some periods with higher betas.
*   **Cap(B):** Market capitalization has fluctuated, generally decreasing in recent years, which aligns with the declining stock performance.

**2. Recent Price Action**

*   **Current Price:** 92.74
*   **Last Market Data:** price': 92.74, 'previousClose': 95.29, 'change': -2.68
*   **Moving Averages:** 5-day (95.75), 20-day (88.48), 60-day (81.42)
*   **Analysis:** The price is below the 5-day moving average but above the 20-day and 60-day moving averages. The recent price decrease from the previous close suggests short-term downward pressure.

**3. Indicators**

*   **Market Risk Indicator (MRI):** 0.5 (Low Investment)
*   **RSI:** 70.42 (Approaching overbought territory)
*   **PPO:** 0.46
*   **Hybrid Signal:** cash_0%_Buy 100% of cash (12 shares - Very Safe - MRI:0.90)
*   **Delta_Previous_Relative_Divergence:** 2.5 (+): 단기상승
*   **Expected Return:** 542.2% (Long-term, relative to S&P 500)
*   **Analysis:**
    *   The MRI suggests a "Low Investment" recommendation.
    *   The RSI indicates the stock is nearing overbought territory, which could signal a potential pullback.
    *   The positive change in relative divergence suggests some recent positive momentum.
    *   The **change**: -2.68 suggests recent volatility issue.
    *   The high expected return is a projection based on the model and should be viewed with caution, considering the historical volatility.
    *   The Hybrid Signal indicates "cash_0%_Buy 100% of cash (12 shares - Very Safe - MRI:0.90)", but we know that the MRI is at "0.5" level, which suggests that this hybrid signal might be faulty or unreliable.

**4. Recent News & Significant Events**

*   **2025-10-19:** Brief market mention.
*   **2025-10-18:** Analyst discussion of short-term outlook.
*   **2025-10-17:** Volatility around earnings or guidance.
*   **2025-10-16:** Sector updates.
*   **Analysis:** The news suggests potential volatility and uncertainty surrounding the stock, possibly related to earnings, guidance, or sector-specific developments. Analyst outlooks are being actively discussed.

**4-2. Analyst Opinions**

*   **Consensus:** Hold (2.72)
*   **Target Price:** Avg: 92.24, High: 200.00, Low: 58.00
*   **Analysis:** Analyst consensus is "Hold."  The average target price is around the current price, but there's a wide range in target prices, indicating uncertainty in future valuation. The lack of recent rating changes suggests analysts are mostly maintaining their current views.

**5. Recent Earnings Analysis**

| 날짜       | EPS    | 매출      |
|------------|--------|-----------|
| 2025-08-04 | -0.16  | 1.33 B$   |
| 2025-04-30 | 0      | 1.08 B$   |
| 2024-11-06 | -9.45  | 1.35 B$   |
| 2024-07-31 | -1.96  | 1.43 B$   |
| 2025-08-04 | -1.96  | 1.43 B$   |

*   **Analysis:**  Recent EPS figures have been negative. Revenue has fluctuated. This indicates potential challenges in profitability.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue  | Profit Margin |
|--------------|----------|---------------|
| 2025-06-30   | $1.33B   | 14.80%        |
| 2025-03-31   | $1.08B   | 14.51%        |
| 2024-12-31   | $1.23B   | 11.22%        |
| 2024-09-30   | $1.35B   | -7.68%        |
| 2024-06-30   | $1.43B   | -0.74%        |

**Capital and Profitability:**

| Quarter      | Equity   | ROE        |
|--------------|----------|------------|
| 2025-06-30   | $10.24B  | 0.22%      |
| 2025-03-31   | $10.03B  | 0.41%      |
| 2024-12-31   | $9.96B   | 0.76%      |
| 2024-09-30   | $10.24B  | -10.44%     |
| 2024-06-30   | $11.22B  | -1.68%     |

*   **Analysis:** Revenue has been fluctuating. Profit margins have shown recent improvement but were negative in some prior quarters. Equity has been relatively stable.  ROE has been low and negative in some periods, reflecting the profitability challenges.

**7. Overall Summary**

ALB has significantly underperformed the S&P 500. Recent performance has been weak, with negative EPS and volatile revenue and profit margins. Analyst consensus is "Hold," but there's a wide range in price targets, reflecting uncertainty. The MRI suggests caution. The RSI is approaching overbought territory, which suggests a potential pullback. The long-term expected return is very high, but this projection should be viewed with skepticism given the stock's recent struggles and high volatility. Recent news headlines suggest ongoing volatility and analyst scrutiny. The hybrid signal indicates "cash_0%_Buy 100% of cash (12 shares - Very Safe - MRI:0.90)", but we know that the MRI is at "0.5" level, which suggests that this hybrid signal might be faulty or unreliable.
